BIOCHEM BIOPH RES CO 润色咨询

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

出版年份:1959 年文章数:31561 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:4.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2024-03-23 ms9000000037149974 来自山东省

    请问BBRC文章查重文献和图例也查吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2024-03-23 ms6000001807387082 来自辽宁省

    稿费多少

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2024-03-20 零零一 来自广西

    效率还可以,稳妥Accept

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2023-12-11 ms1000000877479508 来自海南省

    11天了还是Submitted to journal,请问什么时候能进入下一节点啊

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2023-12-19 寻觅瓦尔登 来自上海

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:动物实验;心血管;基础
    经验分享:投的short communications,时间线参考:
    2023.12.03 Submitted to Journal
    2023.12.14 Pre-review changes required
    2023.12.15 Under Review
    2023.12.18 Accept
    一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。

    9

    展开9条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2024-02-21 ms8000000394868318 来自四川省

    偏重的研究方向:中药生发
    经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2024-02-23 1dd97911m23(暂无匿称) 来自北京

    偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎
    经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2020-07-23 17142086d7m

    审稿速度:1.0 | 投稿命中率:100.0
    偏重的研究方向:神经生物学;细胞生物学;分子生物学
    经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!

    55

    展开55条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2020-05-05 12147f1dm17暂无昵称

    24小时内接受了,果然是神刊!

    26

    展开26条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2194888, encodeId=a44f2194888de, content=请问BBRC文章查重文献和图例也查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13e69228095, createdName=ms9000000037149974, createdTime=Sat Mar 23 18:02:22 CST 2024, time=2024-03-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194841, encodeId=314421948414c, content=稿费多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3f9227750, createdName=ms6000001807387082, createdTime=Sat Mar 23 12:08:06 CST 2024, time=2024-03-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194249, encodeId=417e2194249d3, content=效率还可以,稳妥Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 11:31:37 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2174194, encodeId=63c121e4194a6, content=11天了还是Submitted to journal,请问什么时候能进入下一节点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b708136833, createdName=ms1000000877479508, createdTime=Mon Dec 11 09:14:15 CST 2023, time=2023-12-11, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175767, encodeId=b94121e5767ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:动物实验;心血管;基础<br>经验分享:投的short communications,时间线参考:<br>2023.12.03 Submitted to Journal<br>2023.12.14 Pre-review changes required<br>2023.12.15 Under Review<br>2023.12.18 Accept<br>一共给BBRC投过3次稿,拒稿转投1次,接收2次。这次从Under Review到接收只花了3天,个人感觉是BBRC更注重课题的创新,逻辑思路的清晰和语言的凝练。不需要有过多的数据,但是需要有新意。按照我的经验,越快审稿说明新意越足,中的概率越大。祝大家也顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzaUvYjJ5RKldIwAUubutpwZa2IpTuAibHjwEMk8vGIqwxTR3GEGYzO1jKlxVb3XHe6p8HNUCFt8g/132, createdBy=597d5310028, createdName=寻觅瓦尔登, createdTime=Tue Dec 19 10:51:42 CST 2023, time=2023-12-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188536, encodeId=531a218853681, content=偏重的研究方向:中药生发<br>经验分享:2024.2.18晚上22.54投稿,2.19号凌晨12.59处于Submitted to Journal状态,到今天已经三天了还是Submitted to Journal状态,编号: BBRC-24-1364,期待能有个好结果吧,毕业用,不知道能不能来得及,唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ab8713797, createdName=ms8000000394868318, createdTime=Wed Feb 21 17:21:12 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188858, encodeId=577d21888581a, content=偏重的研究方向:鼻息肉;适应性免疫;人慢性鼻窦炎<br>经验分享:记录一下:投的short communication,编号:24-1285。2024.02.15 Submitted to journal,2024.02.21 Under Review。跪求诸神保佑文章可以accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90a81637022, createdName=1dd97911m23(暂无匿称), createdTime=Fri Feb 23 11:34:34 CST 2024, time=2024-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=55, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590238, encodeId=8fae5902380a, content=24小时内接受了,果然是神刊!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f52242192, createdName=12147f1dm17暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188537, encodeId=4158218853e31, content=2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73869177223, createdName=ms3000000806055068, createdTime=Wed Feb 21 17:36:20 CST 2024, time=2024-02-21, status=1, ipAttribution=四川省)]
    2024-02-21 ms3000000806055068 来自四川省

    2024年2.18号晚上投稿,2.19号凌晨状态为submitted to journal,今天2.21号还是submitted to journal状态,编号为24-1364,希望能有个好结果吧,祈祷能赶上毕业!

    7

    展开7条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分